SUPPRESSA, PATRIZIA
 Distribuzione geografica
Continente #
AS - Asia 4.475
NA - Nord America 3.418
SA - Sud America 3.149
EU - Europa 1.132
AF - Africa 451
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 3
Totale 12.632
Nazione #
US - Stati Uniti d'America 3.226
BR - Brasile 2.453
VN - Vietnam 1.396
SG - Singapore 1.253
CN - Cina 1.056
MA - Marocco 296
AR - Argentina 288
DE - Germania 225
IT - Italia 219
ID - Indonesia 171
NL - Olanda 164
EC - Ecuador 148
PK - Pakistan 122
HK - Hong Kong 121
FR - Francia 97
MX - Messico 96
RU - Federazione Russa 88
CO - Colombia 79
FI - Finlandia 77
BD - Bangladesh 75
IN - India 71
GB - Regno Unito 70
ZA - Sudafrica 64
PY - Paraguay 56
CL - Cile 41
CA - Canada 39
UY - Uruguay 34
IQ - Iraq 33
AT - Austria 29
PE - Perù 27
UA - Ucraina 27
PL - Polonia 23
VE - Venezuela 21
DZ - Algeria 20
JP - Giappone 20
UZ - Uzbekistan 20
DO - Repubblica Dominicana 19
EG - Egitto 18
ES - Italia 18
SE - Svezia 18
TR - Turchia 18
TN - Tunisia 15
AZ - Azerbaigian 13
KE - Kenya 10
PH - Filippine 10
SA - Arabia Saudita 10
AL - Albania 9
BG - Bulgaria 9
GA - Gabon 8
HN - Honduras 8
KW - Kuwait 8
AE - Emirati Arabi Uniti 7
KZ - Kazakistan 7
LV - Lettonia 7
PA - Panama 7
BE - Belgio 6
IE - Irlanda 6
IL - Israele 6
JO - Giordania 6
MY - Malesia 6
CH - Svizzera 5
CR - Costa Rica 5
ET - Etiopia 5
JM - Giamaica 5
SN - Senegal 5
TH - Thailandia 5
BH - Bahrain 4
CZ - Repubblica Ceca 4
LA - Repubblica Popolare Democratica del Laos 4
LB - Libano 4
LK - Sri Lanka 4
LT - Lituania 4
PS - Palestinian Territory 4
XK - ???statistics.table.value.countryCode.XK??? 4
AM - Armenia 3
BW - Botswana 3
CI - Costa d'Avorio 3
GT - Guatemala 3
HU - Ungheria 3
KG - Kirghizistan 3
MD - Moldavia 3
NI - Nicaragua 3
NO - Norvegia 3
NP - Nepal 3
OM - Oman 3
PT - Portogallo 3
RO - Romania 3
BA - Bosnia-Erzegovina 2
BN - Brunei Darussalam 2
BO - Bolivia 2
CY - Cipro 2
EE - Estonia 2
GR - Grecia 2
MN - Mongolia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
Totale 12.621
Città #
Dallas 1.188
Singapore 621
Ho Chi Minh City 529
San Jose 475
Ashburn 332
Hanoi 283
Hefei 283
Casablanca 267
The Dalles 262
São Paulo 199
Los Angeles 190
Beijing 136
Amsterdam 128
Frankfurt am Main 127
Hong Kong 121
Islamabad 88
Rio de Janeiro 82
Chicago 79
Haiphong 68
Helsinki 68
Columbus 60
Curitiba 52
Quito 45
Santa Clara 43
Belo Horizonte 42
Brasília 42
Da Nang 41
Guayaquil 40
New York 40
Porto Alegre 40
Hải Dương 37
Munich 35
Mexico City 34
Thái Bình 33
Campinas 31
Salvador 30
Biên Hòa 29
Hillsboro 29
Montevideo 28
Jakarta 27
Santo André 26
Buenos Aires 25
Ninh Bình 25
Sorocaba 24
Johannesburg 23
Orem 23
Boardman 22
Can Tho 22
Guarulhos 22
Lahore 20
Bắc Ninh 19
Fortaleza 19
Recife 19
Rome 19
Warsaw 19
Bogotá 18
Manaus 18
Ribeirão Preto 18
Tashkent 18
Baghdad 17
Bari 17
Barnet 17
Boston 17
Goiânia 17
Nuremberg 17
Osasco 17
Asunción 16
Council Bluffs 16
Lima 16
Milan 16
São José dos Campos 16
Bắc Giang 15
Cape Town 15
Chennai 15
Hortolândia 15
Sumaré 15
Thái Nguyên 15
Bauru 14
Boydton 14
Piracicaba 14
Santiago 14
Tokyo 14
Toronto 14
Baku 13
Caxias do Sul 13
Ha Long 13
Joinville 13
Montreal 13
Moscow 13
Mumbai 13
Contagem 12
Lấp Vò 12
Rio Claro 12
Santo Domingo 12
São Bernardo do Campo 12
Volta Redonda 12
Canoas 11
Düsseldorf 11
Matera 11
Montes Claros 11
Totale 7.263
Nome #
13C-methacetin breath test: A new tool to predict the presence of liver vascular malformations in patients with hereditary haemorragic teleangiectasia 587
A long diagnostic delay in patients with Hereditary Haemorrhagic Telangiectasia: A questionnaire-based retrospective study 118
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 100
Pain and Frailty in Hospitalized Older Adults 94
"Si riconosce ciò che si conosce”: diagnosi forse tardiva di un caso raro di tumore neuroendocrino, il glucagonoma 81
"A secret Weapon" for diagnosis of HHT: the echo-color-Doppler study of the liver 79
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 75
A strange case from “the land of eagles” 74
Involvement of the transforming growth factor beta in the pathogenesis of hereditary hemorrhagic telangiectasia 73
Il fenotipo Hyper TG-Waist: un nuovo marker di rischio cardiovascolare nel paziente geriatrico 73
What changed in the Italian internal medicine and geriatric wards during the lockdown 71
A low prevalence of clinical manifestations conceals a much more frequent liver involvement in hereditary hemorrhagic telangiectasia (HHT). 71
A new risk factor for cardiovascular disease in elderly: the HyperTg-waist phenotype 71
A case of brain vanishing tumor 70
Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study 69
A long diagnostic delay in patients with Hereditary Haemorrhagic Telangiectasia: A questionnaire-based retrospective study 69
Effects of VEGF on phenotypic severity in children with hereditary hemorrhagic telangiectasia 68
A low prevalence of clinical manifestations conceals a much more frequent liver involvement in hereditary hemorrhagic telangiectasia (HHT) 68
Another case of diagnostic delay brings about a serious brain abscess with complex clinical management 68
HHT: a rare disease with broad spectrum of clinical aspects 67
Efficacia dello screening genetico nella prevenzione del rischio tumorale e nella riduzione della mortalità in pazienti affetti da Sindrome di Lynch (HNPCC) 67
The impact of cognitive level on disability in an aged population with Alzheimer disease 67
Large B cells non-Hodgkin lymphoma in a patient with chronic HBV infection 66
Ultrasonographic analysis of HAVMS in a large cohort of hereditary hemorrhagic telangiectasia patients: definition of a new highly-accurate intrahepatic parameter 65
Characterization of epidemiological distribution and outcome of COVID-19 in patients with hereditary hemorrhagic telangiectasia: a nationwide retrospective multi-centre study during first wave in Italy 65
Quando la politica incontra la sanità e la scienza: l'approccio della Regione Puglia all'assistenza dei pazienti con malattie rare 65
Screening con EGDS nella Teleangiectasia Emorragica Ereditaria (HHT) 64
Behavioural disorders and Alzheimer disease 64
Ultrasonographic Analysis of HAVMs in a large cohort of Hereditary Hemorrhagic Telangiectasia patients: definition of a new highly accurate intrahepatic parameter 64
Diet and myocardial infarction: a nested case-control study in a cohort of elderly subjects in a Mediterranean area of southern Italy 63
Shunts intraepatici e seminoma: insieme per caso? 61
Malnutrizione: impatto sulla disabilità e mortalità in una popolazione anziana 61
Hepatic involvement and stiffness evaluation by elastography in hereditary hemorrhagic telangiectasia 60
A chance for HoFH 60
Thyroid nodules malignancy is associated with increased non-invasive hepatic fibrosis scores in metabolic subjects 60
A case of sarcoidosis with isolated hepatosplenic onset and development of inflammatory bowel disease during recovery stage 60
Relationship of serum free thyroxine (fT4) and thyroid stimulating hormone (TSH) with insulin resistance in an aged obese euthyroid population. 60
Risk factors for three-month mortality after discharge in a cohort of non-oncologic hospitalized elderly patients: Results from the REPOSI study 59
Effects of double filtration plasmapheresis (DFPP) in nephrotic syndrome of hiv-associeted lupus-like glomerulonephritis 59
A spike at tumor onset earmarks low level instability in perpheral blood cells from Lynch Syndrome patients 59
Diet and myocardial infarction: A nested case-control study in a cohort of elderly subjects in a Mediterranean area of southern Italy 59
The lower is better”: genetic pitfalls of a paradigmatic approach for dyslipidemia 59
Total serum FGF-21 levels positively relate to visceral adiposity differently from its functional intact form 58
Sintomi clinici e prevalenza in una popolazione anziana sensibilizzata all'Anisakis 58
Safety of reduced or absent antithrombotic therapy after left atrial appendage closure in patients affected by hereditary haemorrhagic telangiectasia and atrial fibrillation 58
Hereditary haemorrhagic telangiectasia and oral anticoagulation: efficacy of percutaneous left atrial appendage occlusion in patients with non-valvular atrial fibrillation 57
IDENTIFICATION AND VALIDATION OF THE CHRONO MED DIET SCORE: A SURVEY IN 9200 SUBJECTS 56
Real-world efficacy and safety of Inclisiran: a prospective cohort study 56
Evaluation of lipoprotein(a) in the prevention and management of atherosclerotic cardiovascular disease: A survey among the Lipid Clinics Network 55
Multi-source approach permits a better ascertainment and provides more reliable estimates of Hereditary Haemorrhagic Telangiectasia: a population-based study in Apulia, Italy 55
Manifestazioni cliniche in un'ampia coorte di pazienti pediatrici affetti da Teleangiectasia Emorragica Ereditaria 55
A low prevalence of clinical manifestations conceals a much more frequent liver involvement in hereditary hemorrhagic telangiectasia (HHT). 55
Coinvolgimento cerebrale in un campione esteso di pazienti italiani con Teleangiectasia Emorragica Ereditaria 55
Risk of pulmonary embolism and deep vein thrombosis in sarcoidosis: a systematic review and meta-analysis 55
Asymptomatic microhematuria: an indication of hereditary hemorrhagic telangiectasia? 54
Multifactorial thrombosis: a case report 54
Cardiovascular risk in sarcoidosis: a prognostic stratification model based on subclinical atherosclerosis evaluation 54
Hepatic involvement and atrial fibrillation in geriatric patients with hereditary haemorrhagic telangiectasia 54
La malattia celiaca non è più rara, ma a volte l'esordio è subdolo 54
Longitudinal study of natural history of arteriovenous malformations in evolutionary age of Hereditary haemorrhagic telangiectasia 54
Diagnostic delay in rare diseases: the drama of a silent killer 53
Influence of genetics and metabolic factors on neutrophil-to-high density lipoprotein cholesterol ratio: a perspective observational study 53
Life expectancy in patients with heredetary haemorrhagic teleangectasia 53
The Role of Registers in Increasing Knowledge and Improving Management of Children and Adolescents Affected by Familial Hypercholesterolemia: the LIPIGEN Pediatric Group 53
Diet and myocardial infarction: A nested case-control study in a cohort of elderly subjects in a Mediterranean area of southern Italy 53
Abdominal obesity negatively influences key metrics of reverse cholesterol transport 52
A different negative T-wave interpretation 52
Uso dell'Angio-RM dinamica nello studio delle alterazioni parenchimali epatiche di pazienti affetti da HHT: esperienza preliminare 52
Statins, ACE/ARBs drug use, and risk of pneumonia in hospitalized older patients: a retrospective cohort study 52
Orticaria e angioedema nei pazienti geriatrici 52
Gender, BMI and fasting hyperglycaemia influence Monocyte to-HDL ratio (MHR) index in metabolic subjects 52
Braving the tide: the impact of the CoV-2 pandemic on quality of life, disease characteristics and trust in public health services in hereditary haemorrhagic telangiectasia and sarcoidosis patients 52
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 52
Patients affected by Hereditary Hemorragic Telangiectasia (rara disease) wait for the correct diagnosis more than 30 years 51
Refinement of the diagnostic approach for the identification of children and adolescents affected by familial hypercholesterolemia: Evidence from the LIPIGEN study 51
Capacità funzionale dei pazienti con malformazioni artero-venose polmonari diffuse: valutazione con test da sforzo al cicloergometro 51
Patient with Hereditary Haemorrhagic Telangiectasia wait >30 years on average to receive a correct diagnosis 50
Impact of electronic cigarettes (e-cigs) and heat-not-burn/heated tobacco products (HnB/HTP) on asthma and chronic obstructive pulmonary disease: a viewpoint of the Italian Society of Internal Medicine 50
The clinical labyrinth of chronic granulomatous diseases: not only sarcoidosis 50
Rapida ed efficiente caratterizzazione di mutazioni in pazienti con Teleangiectasia Emorragica Ereditaria mediante DHPLC 50
A peddler in a bizzarre body 50
Novel approach to idursulfase and laronidase desensitization in type 2 and type 1 S mucopolysaccharidosis (MPS) 49
Platelet to gamma-glutamyl transferase ratio: a novel easy-to-use tool to predict high lipoprotein(a) levels 49
Drug-drug interactions involving CYP3A4 and p-glycoprotein in hospitalized elderly patients 49
Prevalence, characteristics and treatment of chronic pain in elderly patients hospitalized in internal medicine wards 49
Coffee intake and mild cognitive impairment (MCI): prospective study on a large color of elderly italian subject 49
Polypharmacy in older people: Lessons from 10 years of experience with the REPOSI register 49
AST to Platelet Ratio Index (APRI) is an easy-to-use predictor score for cardiovascular risk in metabolic subjects 49
Life expectancy in patients with hereditary haemorrhagic telangiectasia 49
Homozygous familial hypercholesterolemia in Italy: Clinical and molecular features 48
Effects of VEGF on Phenotypic Severity in Children With Hereditary Hemorrhagic Telangiectasia 48
Liver involvement associated to hereditary haemmorrhagic telangiectasia in pediatric age 48
Come superare le barriere all’implementazione delle strategie di prevenzione e cura della malattia cardiovascolare aterosclerotica mediante terapia ipolipemizzante 48
Characterization and clinical management of statin intolerance in a cohort of hyperlipidemic subjects 48
A real-world follow-up experience of PCSK9i use in Bari Lipigen Center 48
Development of the “medical attitudes towards deprescribing questionnaire” (MATD-Q) 48
A rare case of intramuscular abscess in a patient with hereditary haemorrhagic telangiectasia 48
THE PORTRAIT OF “MRS GREYSH”: AN UNUSUAL PRESENTATION OF ALKAPTONURIA 47
Long-term effectiveness and safety of lomitapide in patients with homozygous familial hypercholesterolemia: an observational case series 47
Congenital analbuminemia in a patient affected by hypercolesterolemia 47
Totale 6.411
Categoria #
all - tutte 84.173
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 84.173


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/20251.643 0 0 0 367 74 274 91 86 260 92 270 129
2025/202611.291 169 1.302 2.254 3.870 286 167 992 601 599 704 276 71
Totale 12.934